DETAILS OF ETHICS APPROVAL
The study was reviewed and approved by the Institutional Review Boards
at University of California, Berkeley (Protocol #2017-03-9670; Dated
4th April 2017) and Public Health Research Institute
of India, Mysore (Protocol #2017-04-01-36; Dated 1stApril 2017).
REFERENCES
1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and
mortality worldwide: sources, methods and major patterns in GLOBOCAN
2012. Int J Cancer. 2015;136(5):E359-386.
2. World Health Organization. Cervical Cancer.https://wwwwhoint/health-topics/cervical-cancer#tab=tab_1.2020.
3. Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H. An overview
of cancer survival in Africa, Asia, the Caribbean and Central America:
the case for investment in cancer health services. IARC Sci Publ.2011;162(162):257-291.
4. Sankaranarayanan R. Screening for cancer in low-and middle-income
countries. Annals of global health. 2014;80(5):412-417.
5. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence,
mortality, and prevalence across five continents: defining priorities to
reduce cancer disparities in different geographic regions of the world.J Clin Oncol. 2006;24(14):2137-2150.
6. WHO. Guidelines for screening and treatment of precancerous lesions
for cervical cancer prevention: supplemental material: GRADE
evidence-to-recommendation tables and evidence profiles for each
recommendation, 2013. Available:
https://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/.
7. Racey CS, Gesink DC. Barriers and Facilitators to Cervical Cancer
Screening Among Women in Rural Ontario, Canada: The Role of
Self‐Collected HPV Testing. The Journal of Rural Health. 2015.
8. Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J.
Acceptability of self-collection sampling for HPV-DNA testing in
low-resource settings: a mixed methods approach. BMC public
health. 2014;14(1):596.
9. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH. Cervical
cancer prevention in low-and middle-income countries: feasible,
affordable, essential. Cancer prevention research.2012;5(1):11-17.
10. Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The
acceptability of self-sampled screening for HPV DNA: a systematic review
and meta-analysis. Sex Transm Infect. 2017;93(1):56-61.
11. National Institute of Cancer Prevention and Research, Indian Council
of Medical Research. Globocan 2018: India Factsheet.http://cancerindiaorgin/globocan-2018-india-factsheet/.2018.
12. Bagcchi S. India launches plan for national cancer screening
programme. BMJ. 2016;355:i5574.
13. Mehtal S. HPV screening: 7% pre-malignant cases detected.Times of India 2017;City News.
14. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah K V, et al.
Prevalence and distribution of high-risk human papilloma virus (HPV)
types in invasive squamous cell carcinoma of the cervix and in normal
women in Andhra Pradesh, India. BMC Infect Dis. 2005;5:116.
15. Kuriakose S, Sabeena S, Binesh D, Abdulmajeed J, Ravishankar N,
Ramachandran A, et al. Diagnostic accuracy of self-collected vaginal
samples for HPV DNA detection in women from South India. Int J
Gynaecol Obstet. 2020;149(2):219-224.
16. Adamson PC, Huchko MJ, Moss AM, Kinkel HF, Medina-Marino A.
Acceptability and Accuracy of Cervical Cancer Screening Using a
Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected
Women in South Africa. PloS one. 2015;10(9):e0137299.
17. Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC,
et al. Acceptability of self‐collected versus provider‐collected
sampling for HPV DNA testing among women in rural El Salvador.International Journal of Gynecology & Obstetrics.2014;126(2):156-160.
18. Ma’som M, Bhoo-Pathy N, Nasir NH, Bellinson J, Subramaniam S, Ma Y,
et al. Attitudes and factors affecting acceptability of
self-administered cervicovaginal sampling for human papillomavirus (HPV)
genotyping as an alternative to Pap testing among multiethnic Malaysian
women. BMJ open. 2016;6(8):e011022.
19. Nilyanimit P, Wanlapakorn N, Niruthisard S, Takahashi M,
Vongpunsawad S, Poovorawan Y. Comparison of Detection Sensitivity for
Human Papillomavirus between Self-collected Vaginal Swabs and
Physician-collected Cervical Swabs by Electrochemical DNA Chip.Asian Pacific Journal of Cancer Prevention.2014;15(24):10809-10812.
20. Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, et al. Can
human papillomavirus DNA testing of self-collected vaginal samples
compare with physician-collected cervical samples and cytology for
cervical cancer screening in developing countries? Cancer
Epidemiology. 2009;33(6):446-450.
21. Verma R, Khanna P. Human papilloma virus vaccines Need to be
introduced in India. Human Vaccines & Immunotherapeutics.2013;9(1):97-99.
22. Quincy BL, Turbow DJ, Dabinett LN. Acceptability of self-collected
human papillomavirus specimens as a primary screen for cervical cancer.Journal of Obstetrics and Gynaecology. 2012;32(1):87-91.
23. Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, et
al. High-risk HPV testing on self-sampled versus clinician-collected
specimens: a review on the clinical accuracy and impact on population
attendance in cervical cancer screening. Int J Cancer.2013;132(10):2223-2236.
24. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmeron J, Uribe P,
Velasco-Mondragon E, et al. Self-collection of vaginal specimens for
human papillomavirus testing in cervical cancer prevention (MARCH): a
community-based randomised controlled trial. Lancet.2011;378(9806):1868-1873.
25. Rees I, Jones D, Chen H, Macleod U. Interventions to improve the
uptake of cervical cancer screening among lower socioeconomic groups: A
systematic review. Prev Med. 2018;111:323-335.
26. Adsul P, Srinivas V, Gowda S, Nayaka S, Pramathesh R, Chandrappa K,
et al. A community-based, cross-sectional study of hrHPV DNA
self-sampling-based cervical cancer screening in rural Karnataka, India.Int J Gynaecol Obstet. 2019;146(2):170-176.
27. A Peedicayil, P Abraham, J Prasad, Jeyaseelan L, Abraham S, Kurian
S, et al. Community Prevalence of Human Papillomavirus by Self-Collected
Samples in South India. Indian J Gynecol Oncolog. 2016;14:16.
Table 1: Demographic and Clinical Characteristics Women in
rural Mysore, India (N=120)